Literature DB >> 7930603

Immunosuppressant deoxyspergualin inhibits antigen processing in monocytes.

P H Hoeger1, M A Tepper, A Faith, J A Higgins, J R Lamb, R S Geha.   

Abstract

Deoxyspergualin (DSG) is a novel immunosuppressive agent recently shown to bind to the constitutive heat shock protein 70, which is involved in binding and intracellular transport of antigenic peptides. In this study, we show that DSG inhibits the proliferation of PBMCs to the Ags tetanus toxoid and diphtheria toxoid, but not to the mitogens PHA and PMA/ionomycin, nor to the superantigens toxic shock syndrome toxin-1 and staphylococcal enterotoxin A. DSG's effect was specific for monocytes as preincubation of T cells with DSG did not inhibit their proliferation to monocytes pulsed with tetanus toxoid Ag for 16 h, whereas the presence of DSG during Ag pulsing of the monocytes inhibited their ability to stimulate T cell proliferation. DSG did not down-regulate the expression of MHC class II molecules by monocytes, and the inhibitory effect of DSG on T cell proliferation was not reversed by the addition of IL-2, nor by the addition of the costimulatory signals IL-1, IL-6, and anti-CD28. Studies with two human T cell clones, HA1.7 and PF5, specific, respectively, to peptides spanning amino acids 307-319 and 256-270 of influenza hemagglutinin, showed that DSG inhibited the proliferation of the clones to the native hemagglutinin molecule but minimally affected their proliferation to the peptides. These data suggest that DSG interferes with Ag processing and/or presentation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930603

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

2.  Uncoating ATPase Hsc70 is recruited by invariant chain and controls the size of endocytic compartments.

Authors:  Cécile Lagaudrière-Gesbert; Sherri L Newmyer; Tone F Gregers; Oddmund Bakke; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

3.  Immunosuppressant deoxyspergualin induces apoptotic cell death in dividing cells.

Authors:  C Odaka; E Toyoda; K Nemoto
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

Review 4.  Pharmacological targeting of the Hsp70 chaperone.

Authors:  Srikanth Patury; Yoshinari Miyata; Jason E Gestwicki
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

5.  Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+ B lymphocytes.

Authors:  K Morikawa; K Nemoto; T Miyawaki; S Morikawa
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

6.  Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70.

Authors:  Natalia Zietara; Marcin Łyszkiewicz; Nelson Gekara; Jacek Puchałka; Vitor A P Martins Dos Santos; Clayton R Hunt; Tej K Pandita; Stefan Lienenklaus; Siegfried Weiss
Journal:  J Immunol       Date:  2009-07-15       Impact factor: 5.422

7.  Induction of T regulatory cells attenuates idiopathic nephrotic syndrome.

Authors:  Ludmilla Le Berre; Sarah Bruneau; Jeanne Naulet; Karine Renaudin; Françoise Buzelin; Claire Usal; Helga Smit; Thomas Condamine; Jean-Paul Soulillou; Jacques Dantal
Journal:  J Am Soc Nephrol       Date:  2008-11-19       Impact factor: 10.121

8.  Is there B cell involvement in a rat model of spontaneous idiopathic nephrotic syndrome treated with LF15-0195?

Authors:  Ludmilla Le Berre; Gaëlle Tilly; Jacques Dantal
Journal:  J Nephrol       Date:  2014-03-25       Impact factor: 3.902

9.  Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.

Authors:  Hanns-Martin Lorenz; Wilhelm H Schmitt; Vladimir Tesar; Ulf Müller-Ladner; Ingo Tarner; Ingeborg A Hauser; Falk Hiepe; Tobias Alexander; Heike Woehling; Kyuichi Nemoto; Peter A Heinzel
Journal:  Arthritis Res Ther       Date:  2011-03-01       Impact factor: 5.156

10.  HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family.

Authors:  E Nossner; J E Goldberg; C Naftzger; S C Lyu; C Clayberger; A M Krensky
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.